Viridian Therapeutics, Inc.\DE VRDN Institutional Ownership

NASDAQ VRDN

$19.26 +0.27 (+1.42%)

As of: Oct 2, 2026 · 12:19 PM EDT

Institutions by Trading Activity

216 Institutions

Increased 144 66.7%

Unchanged 22 10.2%

Reduced 50 23.1%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

130.27%

▲+20.48 pp QoQ

Shares Held by Institutions

136.86Mn

of 105.06Mn outstanding

▲+29.24% QoQ

Shares Outstanding

105.06Mn

-31.80Mn held outside 13F filers

Institutional Investors

216

filed 13F for Jun 2026

▼-9 vs prior quarter

Net Shares Added (QoQ)

+30.96Mn

accumulated since last quarter

Value of Holdings

$2.82Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Viridian Therapeutics, Inc.\DE (NASDAQ:VRDN) appears in 216 institutional 13F filings for the quarter ending June 2026.

They owned 130.3% of outstanding stock in June 2026, up from 109.8% the prior quarter.
They increased total shares held in VRDN by 29.24% quarter over quarter, and investors in Viridian Therapeutics, Inc.\DE increased 27.06% from a year ago.
Among the 216 funds, 144 bought more Viridian Therapeutics, Inc.\DE shares, 50 sold down, and 22 held their ground.
Institutional investors collectively held 136.86Mn shares in Viridian Therapeutics, Inc.\DE as of June 2026, up by 30.96Mn shares quarter on quarter, and up 43.16Mn shares year over year.
FMR LLC is the top holder of Viridian Therapeutics, Inc.\DE as of June 30, 2026, with 16.6Mn shares representing 15.8% of outstanding stock.
The largest buyers of Viridian Therapeutics, Inc.\DE for the quarter ending June 2026 were Kynam Capital Management, LP (4.11Mn), Paradigm Biocapital Advisors LP (3.57Mn), PRICE T ROWE ASSOCIATES INC /MD/ (2.54Mn), Deep Track Capital, LP (2.2Mn), Caligan Partners LP (2.19Mn).
The biggest sellers of Viridian Therapeutics, Inc.\DE for the quarter ending June 2026 included CITADEL ADVISORS LLC (2.28Mn), BALYASNY ASSET MANAGEMENT L.P. (1.04Mn), MetLife Investment Management, LLC (655.82K), Federated Hermes, Inc. (654.73K), Venrock Adviser, LLC (624.79K).
Per Business Quant data, the top 10 holders of Viridian Therapeutics, Inc.\DE for the quarter ending June 2026 are FMR LLC (16.6Mn), BlackRock, Inc. (8.55Mn), Bellevue Group AG (6.73Mn), Paradigm Biocapital Advisors LP (6.72Mn), Kynam Capital Management, LP (6.45Mn), State Street Corp (6.12Mn), PRICE T ROWE ASSOCIATES INC /MD/ (5.75Mn), Fairmount Funds Management LLC (5.09Mn), VANGUARD CAPITAL MANAGEMENT LLC (4.58Mn), Deep Track Capital, LP (3.59Mn).

Form 13F Holdings

216 Institutional Holders

Report period 30 Jun, 2026

Total shares held 136.86Mn

Of outstanding 130.27%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	FMR LLC	0000315066	16,604,740	15.80%	▲1,225,363	+7.97%	$305.03Mn
2	BlackRock, Inc.	0002012383	8,551,488	8.14%	▲720,013	+9.19%	$157.09Mn
3	Bellevue Group AG	0001674546	6,731,909	6.41%	▲5,765	+0.09%	$123.67Mn
4	Paradigm Biocapital Advisors LP	0001855655	6,723,788	6.40%	▲3,574,895	+113.53%	$123.52Mn
5	Kynam Capital Management, LP	0001907884	6,453,877	6.14%	▲4,112,225	+175.61%	$118.56Mn
6	State Street Corp	0000093751	6,124,976	5.83%	▲1,452,091	+31.07%	$112.52Mn
7	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	5,748,410	5.47%	▲2,542,375	+79.30%	$105.60K
8	Fairmount Funds Management LLC	0001802528	5,090,928	4.85%	▲1,176,470	+30.05%	$93.52Mn
9	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	4,576,860	4.36%	▲409,659	+9.83%	$84.08Mn
10	Deep Track Capital, LP	0001856083	3,592,740	3.42%	▲2,198,796	+157.74%	$66.00Mn
11	Venrock Adviser, LLC	0001615982	3,257,917	3.10%	▼624,792	-16.09%	$59.85Mn
12	WELLINGTON MANAGEMENT GROUP LLP	0000902219	3,128,362	2.98%	▲49,808	+1.62%	$57.47Mn
13	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	2,752,827	2.62%	▲1,111,350	+67.70%	$50.57Mn
14	GEODE CAPITAL MANAGEMENT, LLC	0001214717	2,501,869	2.38%	▲168,656	+7.23%	$45.97Mn
15	Avoro Capital Advisors LLC	0001633313	2,500,000	2.38%	▲1,000,000	+66.67%	$45.93Mn
16	BAKER BROS. ADVISORS LP	0001263508	2,383,025	2.27%	▲411,347	+20.86%	$43.78Mn
17	Point72 Asset Management, L.P.	0001603466	2,343,208	2.23%	▲2,020,372	+625.82%	$43.04Mn
18	Caligan Partners LP	0001727492	2,193,981	2.09%	▲2,193,981	0.00%	$40.30Mn
19	Novo Holdings A/S	0001388325	2,135,000	2.03%	▲135,000	+6.75%	$39.22Mn
20	TANG CAPITAL MANAGEMENT LLC	0001232621	1,792,626	1.71%	0	0.00%	$32.93Mn

Showing 1 to 20 of 216 holders